A Gawaz

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Ejection Fraction

Advanced Non Small Cell Lung Cancer

Epidermal Growth Factor Receptor

Irritable Bowel Syndrome

Top Venues

Cancer immunology, immunotherapy : CII

This page only lists publications with an associated author ORCID identifier.

Publications

A Gawaz, I Wolff, L Nanz, Lukas Flatz, Andrea Forschner
Efficacy of adjuvant immune checkpoint inhibitors pembrolizumab or nivolumab in melanoma patients ≥ 75 years: results of a real-world cohort including 456 patients. Cancer immunology, immunotherapy : CII 73 (9) (2024)
A Gawaz, I Wolff, L Nanz, Lukas Flatz, Andrea Forschner
Efficacy of adjuvant immune checkpoint inhibitors pembrolizumab or nivolumab in melanoma patients ≥ 75 years: results of a real-world cohort including 456 patients. Cancer immunology, immunotherapy : CII 73 (9) (2024)
A Gawaz, I Wolff, L Nanz, Lukas Flatz, Andrea Forschner
Efficacy of adjuvant immune checkpoint inhibitors pembrolizumab or nivolumab in melanoma patients ≥ 75 years: results of a real-world cohort including 456 patients. Cancer immunology, immunotherapy : CII 73 (9) (2024)
A Gawaz, I Wolff, L Nanz, Lukas Flatz, Andrea Forschner
Efficacy of adjuvant immune checkpoint inhibitors pembrolizumab or nivolumab in melanoma patients ≥ 75 years: results of a real-world cohort including 456 patients. Cancer immunology, immunotherapy : CII 73 (9) (2024)